Study guide

12.1 Applied Cardiovascular & Respiratory Physiology

MRCPI in General Medicine Part I Written

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Strategy & Foundation

1.1 MRCPI Part I Format, Scoring & Standard-Setting 1.2 RCPI BST Curriculum & Single-Best-Answer Exam Strategy

2 Chapter 2: Cardiology & Vascular Medicine

2.1 Acute Coronary Syndromes & Stable Angina 2.2 Tachyarrhythmias, Bradyarrhythmias & Channelopathies 2.3 Heart Failure & Valvular Heart Disease 2.4 Hypertension, Vascular & Pericardial Diseases

3 Chapter 3: Respiratory Medicine

3.1 Asthma, COPD & Airway Diseases 3.2 Pneumonia, Tuberculosis & Respiratory Infections 3.3 Interstitial Lung Disease & Pleural Disorders 3.4 Pulmonary Embolism, Pulmonary Hypertension & Sleep Apnoea

4 Chapter 4: Gastroenterology & Hepatology

4.1 Upper & Lower GI Disorders & Inflammatory Bowel Disease 4.2 Acute & Chronic Liver Disease 4.3 Pancreatitis, Biliary Tract & GI Bleeding 4.4 Malabsorption, GI Motility & Clinical Nutrition

5 Chapter 5: Nephrology & Acid-Base Disorders

5.1 Acute Kidney Injury & Glomerular Diseases 5.2 Chronic Kidney Disease & Renal Replacement Therapy 5.3 Electrolyte Imbalances & Acid-Base Disorders

6 Chapter 6: Endocrinology & Diabetes

6.1 Diabetes Mellitus & Metabolic Complications 6.2 Thyroid & Calcium Disorders 6.3 Adrenal, Pituitary & Endocrine Syndromes

7 Chapter 7: Rheumatology & Clinical Immunology

7.1 Inflammatory Arthritides 7.2 Systemic Autoimmune & Vasculitic Diseases 7.3 Metabolic Bone Disease & Clinical Immunology

8 Chapter 8: Haematology & Medical Oncology

8.1 Anaemias, Haemostasis & Thrombosis 8.2 Leukaemias, Lymphomas & Plasma Cell Disorders 8.3 Medical Oncology & Oncological Emergencies

9 Chapter 9: Neurology & Dermatology

9.1 Stroke & Cerebrovascular Diseases 9.2 Epilepsy, Headache & Movement Disorders 9.3 Neuromuscular & Peripheral Nerve Disorders 9.4 Cutaneous Manifestations of Systemic Disease

10 Chapter 10: Acute Medicine, Critical Care & Geriatrics

10.1 Acute Poisoning & Toxidromes 10.2 Sepsis, Shock & Resuscitation 10.3 Geriatric Syndromes, Frailty & Comprehensive Care

11 Chapter 11: Clinical Pharmacology & Therapeutics

11.1 Pharmacokinetics & Pharmacodynamics 11.2 High-Risk Drug Classes & Prescribing Safety 11.3 Adverse Drug Reactions & Drug Safety

12 Chapter 12: Basic Sciences, Biostatistics & Clinical Ethics

12.1 Applied Cardiovascular & Respiratory Physiology 12.2 Clinical Biochemistry, Molecular Genetics & Microbiology 12.3 Biostatistics, Evidence-Based Medicine & Ethics

12.1 Applied Cardiovascular & Respiratory Physiology

Key Takeaways Explain This Topic AI

Normal cardiac output ranges from 4.0 to 8.0 L/min (cardiac index 2.5–4.0 L/min/m²), while normal Systemic Vascular Resistance (SVR) is 800–1200 dynes·sec/cm⁵.

Arterial oxygen content (CaO₂) is primarily determined by hemoglobin concentration and saturation (CaO₂ = [Hb × 1.34 × SaO₂] + [0.0031 × PaO₂]), delivering ~20 mL O₂/dL blood at normal hemoglobin levels.

The normal Alveolar-arterial (A-a) oxygen gradient on room air is <10–15 mmHg (calculated as (Age/4) + 4); an elevated A-a gradient distinguishes intrinsic pulmonary pathology (V/Q mismatch, shunt, diffusion defect) from hypoventilation.

In metabolic acidosis, physiological respiratory compensation is governed by Winter's formula: expected PaCO₂ = (1.5 × [HCO₃⁻]) + 8 ± 2 mmHg.

Oxygen delivery (DO₂) equals cardiac output multiplied by arterial oxygen content (DO₂ = CO × CaO₂ × 10), normally maintaining ~1000 mL O₂/min.

Last updated: July 2026

  • 12.1 Applied Cardiovascular & Respiratory Physiology
  • Cardiovascular Hemodynamics & Cardiac Cycle Mechanics

Understanding cardiovascular physiology requires mastering the mechanics of the cardiac cycle, ventricular compliance, pressure-volume loops, and systemic hemodynamic parameters. The core determinant of organ perfusion is Cardiac Output (CO) , defined as the product of Heart Rate (HR) and Stroke Volume (SV) ( C O = H R × S V CO = HR \times SV CO = H R × S V ). Normal resting cardiac output ranges from 4.0 to 8.0 L/min. To account for variations in body size, the Cardiac Index (CI) adjusts cardiac output for body surface area ( C I = C O / B S A CI = CO / BSA C I = CO / BS A ), with normal values ranging between 2.5 and 4.0 L/min/m².

Stroke volume (normally 60–100 mL/beat) is determined by three interdependent variables:

Preload : The end-diastolic volume or wall tension of the ventricle prior to contraction. According to the Frank-Starling law, increasing end-diastolic volume expands myocardial fiber length, enhancing cross-bridge formation and stroke volume up to an optimal physiological limit. Left ventricular end-diastolic pressure (LVEDP) is clinically estimated by the Pulmonary Capillary Wedge Pressure (PCWP) (normal: 6–12 mmHg), while right ventricular preload is reflected by Central Venous Pressure (CVP) (normal: 2–8 mmHg).

Afterload : The ventricular wall stress developed during systolic ejection, governed by Laplace's law ( W a l l S t r e s s = P r e s s u r e × R a d i u s 2 × W a l l T h i c k n e s s Wall\ Stress = \frac{Pressure \times Radius}{2 \times Wall\ Thickness} Wa ll St ress = 2 × Wa ll T hi c kn ess P ress u re × R a d i u s ​ ). Left ventricular afterload is clinically reflected by Systemic Vascular Resistance (SVR) , calculated using the formula: S V R = M A P − C V P C O × 80 SVR = \frac{MAP - CVP}{CO} \times 80 S V R = CO M A P − C V P ​ × 80 Normal SVR ranges from 800 to 1200 dynes·sec/cm⁵. Right ventricular afterload is governed by Pulmonary Vascular Resistance (PVR) (normal: <2 Wood units or 50–150 dynes·sec/cm⁵).

Inotropy (Contractility) : The intrinsic force of myocardial contraction independent of loading conditions. Enhanced by beta-1 adrenergic stimulation, extracellular calcium, and digitalis, inotropy shifts the Frank-Starling curve upward and to the left.

Pressure-Volume Loops & Cardiac Work

Ventricular performance is classically depicted using Pressure-Volume (PV) loops. Key landmarks include End-Diastolic Volume (EDV, ~120 mL), End-Systolic Volume (ESV, ~50 mL), and Stroke Volume ( S V = E D V − E S V = 70 mL SV = EDV - ESV = 70\text{ mL} S V = E D V − ES V = 70 mL ). The Ejection Fraction (EF) represents the proportion of blood ejected per contraction ( E F = S V / E D V × 100 % EF = SV / EDV \times 100\% EF = S V / E D V × 100% , normal: 55–70%).

Changes in loading conditions produce distinct alterations on the PV loop:

Increased Preload : Widens the PV loop rightward (increased EDV) with a modest increase in SV.

Increased Afterload : Heightens the peak systolic pressure, increases ESV, and narrows the SV.

Increased Contractility : Shifts the End-Systolic Pressure-Volume Relationship (ESPVR) slope upward and leftward, decreasing ESV and increasing SV.

Hemodynamic Profiles in Shock States

Differentiation of shock etiologies relies on invasive or non-invasive hemodynamic monitoring. The table below outlines the classic profiles tested on the MRCPI exam.

  • Shock Class CVP / Preload PCWP Cardiac Output (CO) SVR (Afterload) Mixed Venous S v O 2 SvO_2 S v O 2 ​
  • Hypovolemic Decreased (<2 mmHg) Decreased (<6 mmHg) Decreased Elevated (>1200 dynes) Decreased (<65%)

Cardiogenic Elevated (>12 mmHg) Elevated (>18 mmHg) Severely Decreased Severely Elevated Severely Decreased (<50%)

Vasodilatory (Septic) Decreased or Normal Decreased or Normal Elevated (Early) Severely Low (<600 dynes) Elevated (>75%)

  • Obstructive (PE/Tamponade) Elevated (CVP high) Variable (Low in PE) Decreased Elevated Decreased
  • Respiratory Mechanics & Ventilation-Perfusion (V/Q) Matching

Respiratory physiology focuses on pulmonary ventilation, gas transport across the alveolar-capillary membrane, and ventilation-perfusion matching throughout the lung zones.

The Alveolar Gas Equation & A-a Gradient

Alveolar partial pressure of oxygen ( P A O 2 PAO_2 P A O 2 ​ ) is determined by the Alveolar Gas Equation : P A O 2 = F i O 2 × ( P a t m − P H 2 O ) − P a C O 2 R PAO_2 = FiO_2 \times (P_{atm} - P_{H_2O}) - \frac{PaCO_2}{R} P A O 2 ​ = F i O 2 ​ × ( P a t m ​ − P H 2 ​ O ​ ) − R P a C O 2 ​ ​

On room air ( F i O 2 = 0.21 FiO_2 = 0.21 F i O 2 ​ = 0.21 ) at sea level ( P a t m = 760 mmHg P_{atm} = 760\text{ mmHg} P a t m ​ = 760 mmHg , P H 2 O = 47 mmHg P_{H_2O} = 47\text{ mmHg} P H 2 ​ O ​ = 47 mmHg ) with a respiratory quotient ( R R R ) of 0.8: P A O 2 = 0.21 × ( 760 − 47 ) − P a C O 2 0.8 = 150 − ( 1.25 × P a C O 2 ) PAO_2 = 0.21 \times (760 - 47) - \frac{PaCO_2}{0.8} = 150 - (1.25 \times PaCO_2) P A O 2 ​ = 0.21 × ( 760 − 47 ) − 0.8 P a C O 2 ​ ​ = 150 − ( 1.25 × P a C O 2 ​ )

The Alveolar-arterial (A-a) Oxygen Gradient evaluates the efficiency of gas transfer: A - a Gradient = P A O 2 − P a O 2 A\text{-}a\text{ Gradient} = PAO_2 - PaO_2 A - a Gradient = P A O 2 ​ − P a O 2 ​

Normal A-a gradient on room air is <10–15 mmHg, or estimated as ( A g e / 4 ) + 4 (Age / 4) + 4 ( A g e /4 ) + 4 .

Causes of Hypoxemia Classified by A-a Gradient:

Normal A-a Gradient Hypoxemia :

Alveolar Hypoventilation (opioid overdose, neuromuscular weakness, CNS depression). P a C O 2 PaCO_2 P a C O 2 ​ is elevated, but the lung parenchyma is normal.

Low FiO₂ (high altitude).

Elevated A-a Gradient Hypoxemia :

Ventilation-Perfusion (V/Q) Mismatch (pulmonary embolism, asthma, COPD, mild pneumonia). Responds readily to supplemental oxygen.

Right-to-Left Shunt (ARDS, severe lobar pneumonia, cyanotic congenital heart disease, pulmonary arteriovenous malformations). Refractory to 100% F i O 2 FiO_2 F i O 2 ​ therapy because shunted blood bypasses ventilated alveoli.

Diffusion Impairment (idiopathic pulmonary fibrosis, systemic sclerosis ILD). Worsens significantly with exercise.

Oxygen Delivery & Hemoglobin Dissociation Dynamics

Total arterial oxygen content ( C a O 2 CaO_2 C a O 2 ​ ) accounts for hemoglobin-bound oxygen and dissolved oxygen: C a O 2 = ( H b × 1.34 × S a O 2 ) + ( 0.0031 × P a O 2 ) CaO_2 = (Hb \times 1.34 \times SaO_2) + (0.0031 \times PaO_2) C a O 2 ​ = ( H b × 1.34 × S a O 2 ​ ) + ( 0.0031 × P a O 2 ​ )

At normal values ( H b = 15 g/dL Hb = 15\text{ g/dL} H b = 15 g/dL , S a O 2 = 98 % SaO_2 = 98\% S a O 2 ​ = 98% , P a O 2 = 90 mmHg PaO_2 = 90\text{ mmHg} P a O 2 ​ = 90 mmHg ): C a O 2 = ( 15 × 1.34 × 0.98 ) + ( 0.0031 × 90 ) ≈ 19.7 + 0.28 = 20 mL O 2 / dL CaO_2 = (15 \times 1.34 \times 0.98) + (0.0031 \times 90) \approx 19.7 + 0.28 = 20\text{ mL } O_2/\text{dL} C a O 2 ​ = ( 15 × 1.34 × 0.98 ) + ( 0.0031 × 90 ) ≈ 19.7 + 0.28 = 20 mL O 2 ​ / dL .

Systemic Oxygen Delivery ( D O 2 DO_2 D O 2 ​ ) is calculated as: D O 2 = C O × C a O 2 × 10 ≈ 5.0 L/min × 200 mL/L = 1000 mL O 2 / min DO_2 = CO \times CaO_2 \times 10 \approx 5.0\text{ L/min} \times 200\text{ mL/L} = 1000\text{ mL } O_2/\text{min} D O 2 ​ = CO × C a O 2 ​ × 10 ≈ 5.0 L/min × 200 mL/L = 1000 mL O 2 ​ / min

The Oxygen-Hemoglobin Dissociation Curve displays a sigmoidal shape due to cooperative binding. The P50 represents the P a O 2 PaO_2 P a O 2 ​ at which hemoglobin is 50% saturated (normally ~26.8 mmHg).

Right Shift (Decreased Affinity, Enhanced O 2 O_2 O 2 ​ Unloading to Tissues) : Higher P50. Induced by Acidosis ( H + H^+ H + elevation), Hypercapnia (Bohr effect), Increased Temperature , and Elevated 2,3-Bisphosphoglycerate (2,3-DPG) (adaptive response to chronic hypoxia or anemia).

Left Shift (Increased Affinity, Impaired O 2 O_2 O 2 ​ Release) : Lower P50. Induced by Alkalosis , Hypothermia , Decreased 2,3-DPG (stored blood transfusion), Carboxyhemoglobinemia (carbon monoxide poisoning), Methemoglobinemia , and Fetal Hemoglobin (HbF) .

Step-by-Step Arterial Blood Gas (ABG) & Acid-Base Physiology

Systematic blood gas interpretation follows a strict 4-step algorithm:

Assess pH : Normal: 7.35–7.45. Acidemia: pH < 7.35. Alkalemia: pH > 7.45.

Determine Primary Process : Compare pH with P a C O 2 PaCO_2 P a C O 2 ​ (normal 35–45 mmHg) and [ H C O 3 − ] [HCO_3^-] [ H C O 3 − ​ ] (normal 22–26 mEq/L).

Calculate Expected Compensation :

Metabolic Acidosis : Winter's Formula: Expected P a C O 2 = ( 1.5 × [ H C O 3 − ] ) + 8 ± 2 PaCO_2 = (1.5 \times [HCO_3^-]) + 8 \pm 2 P a C O 2 ​ = ( 1.5 × [ H C O 3 − ​ ]) + 8 ± 2 . If measured P a C O 2 > Expected PaCO_2 > \text{Expected} P a C O 2 ​ > Expected , co-existing respiratory acidosis exists. If measured P a C O 2 < Expected PaCO_2 < \text{Expected} P a C O 2 ​ < Expected , co-existing respiratory alkalosis exists.

Metabolic Alkalosis : Expected P a C O 2 = 0.7 × [ H C O 3 − ] + 21 ± 2 PaCO_2 = 0.7 \times [HCO_3^-] + 21 \pm 2 P a C O 2 ​ = 0.7 × [ H C O 3 − ​ ] + 21 ± 2 .

Acute Respiratory Acidosis : [ H C O 3 − ] [HCO_3^-] [ H C O 3 − ​ ] increases by 1 mEq/L per 10 mmHg rise in P a C O 2 PaCO_2 P a C O 2 ​ above 40.

Chronic Respiratory Acidosis : [ H C O 3 − ] [HCO_3^-] [ H C O 3 − ​ ] increases by 3.5–4 mEq/L per 10 mmHg rise in P a C O 2 PaCO_2 P a C O 2 ​ above 40.

Acute Respiratory Alkalosis : [ H C O 3 − ] [HCO_3^-] [ H C O 3 − ​ ] decreases by 2 mEq/L per 10 mmHg drop in P a C O 2 PaCO_2 P a C O 2 ​ below 40.

Chronic Respiratory Alkalosis : [ H C O 3 − ] [HCO_3^-] [ H C O 3 − ​ ] decreases by 4–5 mEq/L per 10 mmHg drop in P a C O 2 PaCO_2 P a C O 2 ​ below 40.

Calculate Serum Anion Gap (AG) : A G = [ N a + ] − ( [ C l − ] + [ H C O 3 − ] ) AG = [Na^+] - ([Cl^-] + [HCO_3^-]) A G = [ N a + ] − ([ C l − ] + [ H C O 3 − ​ ]) Normal AG: 8–12 mEq/L. (Adjust for hypoalbuminemia: add 2.5 mEq/L to AG for every 1.0 g/dL drop in serum albumin below 4.0 g/dL).

Diagnostic Framework for Metabolic Acidosis

Category Etiologies Pathophysiology / Mechanism

High Anion Gap (HAGMA) GOLD MARK : Glycols (ethylene/propylene), Oxoproline (acetaminophen), L-lactate, D-lactate, Methanol, Aspirin, Renal failure (uremia), Ketoacidosis (DKA, alcoholic, starvation) Accumulation of unmeasured organic acids consuming H C O 3 − HCO_3^- H C O 3 − ​

Normal Anion Gap (NAGMA / Hyperchloremic) HARDUPS : Hyperalimentation, Acetazolamide / Addison's, Renal Tubular Acidosis (RTA Types 1, 2, 4), Diarrhea / GI loss, Ureteral diversions, Spironolactone Direct loss of H C O 3 − HCO_3^- H C O 3 − ​ compensated by renal chloride retention

MRCPI Exam Pearl: In High Anion Gap Metabolic Acidosis, calculate the Delta-Delta Ratio ( Δ AG / Δ H C O 3 − \Delta\text{AG} / \Delta HCO_3^- Δ AG /Δ H C O 3 − ​ ) : Measured AG − 12 24 − Measured H C O 3 − \frac{\text{Measured AG} - 12}{24 - \text{Measured } HCO_3^-} 24 − Measured H C O 3 − ​ Measured AG − 12 ​ .

Ratio < 0.4–0.8 : Mixed HAGMA and Normal Anion Gap Metabolic Acidosis (e.g., severe diarrhea plus ketoacidosis).

Ratio 1.0–2.0 : Pure HAGMA (e.g., uncomplicated DKA or lactic acidosis).

Ratio > 2.0 : Pre-existing or co-existing Metabolic Alkalosis (e.g., severe vomiting plus DKA).